Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases SCIENTIFIC REPORTS 2018
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection PLOS ONE 2018
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 2018
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals. An observational cohort study BMC MEDICINE 2018
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report MEDICINE 2018
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes CLINICAL MICROBIOLOGY AND INFECTION 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison HIV MEDICINE 2018
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy BMC PUBLIC HEALTH 2018
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets VIRUSES 2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis INFECTION 2018
Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence SCIENTIFIC REPORTS 2018
Detection of biofilm-associated implant pathogens in cardiac device infections: High sensitivity of sonication fluid culture even in the presence of antimicrobials JOURNAL OF GLOBAL INFECTIOUS DISEASES 2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study BMC INFECTIOUS DISEASES 2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters IMMUNOBIOLOGY 2018
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne REVUE DU RHUMATISME 2018
Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant enterobacteriaceae: a single-center, observational study BIOMED RESEARCH INTERNATIONAL 2018
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp) JOURNAL OF INFECTION 2017
Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report BMC RESEARCH NOTES 2017
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus CLINICAL MICROBIOLOGY AND INFECTION 2017

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma